UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer

Journal of clinical oncology, 1996-04, Vol.14 (4), p.1128-1135

1996

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Temozolomide on a Daily-for-5-Days Schedule in Patients With Advanced Solid Malignancies

Journal of clinical oncology, 1999-08, Vol.17 (8), p.2604-2613

1999

Volltextzugriff (PDF)

A phase I evaluation of multitargeted antifolate (MTA, Ly231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation

Cancer chemotherapy and pharmacology, 1999, Vol.44 (5), p.372-380

1999

Volltextzugriff (PDF)

Initial phase I evaluation of the novel thymidylate synthase inhibitor, LY231514, using the modified continual reassessment method for dose escalation

Journal of clinical oncology, 1995-11, Vol.13 (11), p.2842-2850

1995

Volltextzugriff (PDF)

Overview of phase I trials of multitargeted antifolate (MTA, LY231514)

Seminars in oncology, 1999-04, Vol.26 (2 Suppl 6), p.82

Rinaldi, D A

1999

Volltextzugriff (PDF)

Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks

Annals of oncology, 2001-11, Vol.12 (11), p.1631-1641

2001

Volltextzugriff (PDF)

Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors

Annals of oncology, 1998-07, Vol.9 (7), p.733-738

1998

Volltextzugriff (PDF)

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

Journal of clinical oncology, 2023-08, Vol.41 (23), p.3881-3890

2023

Volltextzugriff (PDF)

Phase I and pharmacokinetic studies of topotecan administered as a 72 or 120 h continuous infusion

Anti-cancer drugs, 1994-08, Vol.5 (4), p.394-402

1994

Volltextzugriff (PDF)

A phase I trial of gemcitabine and infusional 5-fluorouracil (5-FU) in patients with refractory solid tumors: Louisiana Oncology Associates Protocol No. 1 (LOA-1)

American journal of clinical oncology, 2000-02, Vol.23 (1), p.78-82

2000

Volltextzugriff (PDF)

A randomized phase I trial of chronic oral etoposide with or without granulocyte-macrophage colony-stimulating factor in patients with advanced malignancies

Cancer research (Chicago, Ill.), 1993-12, Vol.53 (24), p.5929-5933

1993

Volltextzugriff (PDF)

Phase II trial of docetaxel for cholangiocarcinoma

American journal of clinical oncology, 1999-02, Vol.22 (1), p.78-81

1999

Volltextzugriff (PDF)

PENSANDO AS MEDIAÇÕES PARA A TRANSFORMAÇÃO SOCIAL: UMA RESENHA CRÍTICA

Educação em revista, 2019, Vol.35

ROSA, GRAZIELA RINALDI DA

2019

Volltextzugriff (PDF)

A bioavailability and pharmacokinetic study of oral and intravenous hydroxyurea

Blood, 1998-03, Vol.91 (5), p.1533-1541

1998

Volltextzugriff (PDF)

Contribution of PET Imaging to the Diagnosis of Septic Embolism in Patients With Pacing Lead Endocarditis

JACC. Cardiovascular imaging, 2016-03, Vol.9 (3), p.283-290

2016

Volltextzugriff (PDF)

Atrial fibrillation in cardiac resynchronization therapy

Heart rhythm O2, 2021-12, Vol.2 (6), p.784-795

2021

Volltextzugriff (PDF)

Electrocardiographic imaging of His bundle, left bundle branch, epicardial, and endocardial left ventricular pacing to achieve cardiac resynchronization therapy

HeartRhythm case reports, 2020-07, Vol.6 (7), p.460-463

2020

Volltextzugriff (PDF)

Noninvasive electrocardiographic assessment of ventricular activation and remodeling response to cardiac resynchronization therapy

Heart rhythm O2, 2021-02, Vol.2 (1), p.12-18

2021

Volltextzugriff (PDF)

Comparison of delayed transvenous reimplantation and immediate surgical epicardial approach in pacing-dependent patients undergoing extraction of infected permanent pacemakers

Heart rhythm, 2015-06, Vol.12 (6), p.1209-1215

2015

Volltextzugriff (PDF)

Preoperative therapy with concurrent paclitaxel/carboplatin/infusional 5-FU and radiation therapy in locoregional esophageal cancer: final results of a Minnie Pearl Cancer Research Network phase II trial

The cancer journal (Sudbury, Mass.), 2003-07, Vol.9 (4), p.251-260

2003

Volltextzugriff (PDF)

Optimizing electrical efficacy of leadless cardiac resynchronization therapy and leadless left ventricular septal pacing: Insights on left and right ventricular activation from electrocardiographic imaging

Heart rhythm O2, 2024-08, Vol.5 (8), p.551-560

2024

Volltextzugriff (PDF)

Overview of phase I trials of multitargeted antifolate (MTA, LY231514): MTA, a novel multitargeted antifolate from preclinical to phase I and behond

Seminars in oncology, 1999, Vol.26 (2), p.82-88

RINALDI, D. A

1999

Volltextzugriff (PDF)

Increase in right ventricular lead pacing threshold following stereotactic ablative therapy for ventricular tachycardia

HeartRhythm case reports, 2023-08, Vol.9 (8), p.555-559

2023

Volltextzugriff (PDF)

Phase II study of 13-cis-retinoic acid and interferon-alpha 2a in patients with advanced squamous cell lung cancer

Anti-cancer drugs, 1993-02, Vol.4 (1), p.33

1993

Volltextzugriff (PDF)

Outcome of elderly (≥70 years) non-small cell lung cancer (NSCLC) patients on a multicenter, phase III randomized trial comparing weekly vs. standard schedules of paclitaxel (P) plus carboplatin (C)

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.7149-7149

2005

Volltextzugriff (PDF)

1 – 25 von 3.532

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.989)
Mit Volltextzugriff
(2.882)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.992)
Life Sciences & Biomedicine
(1.430)
Humans
(1.188)
Female
(710)
Male
(672)
Biological And Medical Sciences
(567)
Middle Aged
(540)
Medical Sciences
(486)
Physical Sciences
(442)
Aged
(439)
Adult
(404)
Technology
(317)
Physics
(284)
Animals
(265)
Cardiovascular System & Cardiology
(228)
Cardiac & Cardiovascular Systems
(208)
Prospective Studies
(198)
Risk Factors
(197)
Treatment Outcome
(189)
Oncology
(188)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer

Phase I and Pharmacokinetic Study of Temozolomide on a Daily-for-5-Days Schedule in Patients With Advanced Solid Malignancies

A phase I evaluation of multitargeted antifolate (MTA, Ly231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation

Initial phase I evaluation of the novel thymidylate synthase inhibitor, LY231514, using the modified continual reassessment method for dose escalation

Overview of phase I trials of multitargeted antifolate (MTA, LY231514)

Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks

Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

Phase I and pharmacokinetic studies of topotecan administered as a 72 or 120 h continuous infusion

A phase I trial of gemcitabine and infusional 5-fluorouracil (5-FU) in patients with refractory solid tumors: Louisiana Oncology Associates Protocol No. 1 (LOA-1)

A randomized phase I trial of chronic oral etoposide with or without granulocyte-macrophage colony-stimulating factor in patients with advanced malignancies

Phase II trial of docetaxel for cholangiocarcinoma

PENSANDO AS MEDIAÇÕES PARA A TRANSFORMAÇÃO SOCIAL: UMA RESENHA CRÍTICA

A bioavailability and pharmacokinetic study of oral and intravenous hydroxyurea

Contribution of PET Imaging to the Diagnosis of Septic Embolism in Patients With Pacing Lead Endocarditis

Atrial fibrillation in cardiac resynchronization therapy

Electrocardiographic imaging of His bundle, left bundle branch, epicardial, and endocardial left ventricular pacing to achieve cardiac resynchronization therapy

Noninvasive electrocardiographic assessment of ventricular activation and remodeling response to cardiac resynchronization therapy

Comparison of delayed transvenous reimplantation and immediate surgical epicardial approach in pacing-dependent patients undergoing extraction of infected permanent pacemakers

Preoperative therapy with concurrent paclitaxel/carboplatin/infusional 5-FU and radiation therapy in locoregional esophageal cancer: final results of a Minnie Pearl Cancer Research Network phase II trial

Optimizing electrical efficacy of leadless cardiac resynchronization therapy and leadless left ventricular septal pacing: Insights on left and right ventricular activation from electrocardiographic imaging

Overview of phase I trials of multitargeted antifolate (MTA, LY231514): MTA, a novel multitargeted antifolate from preclinical to phase I and behond

Increase in right ventricular lead pacing threshold following stereotactic ablative therapy for ventricular tachycardia

Phase II study of 13-cis-retinoic acid and interferon-alpha 2a in patients with advanced squamous cell lung cancer

Outcome of elderly (≥70 years) non-small cell lung cancer (NSCLC) patients on a multicenter, phase III randomized trial comparing weekly vs. standard schedules of paclitaxel (P) plus carboplatin (C)

Suchergebnisse filtern